期刊文献+

骨癌痛大鼠脊髓趋化因子受体2与P38丝裂原活化蛋白激酶信号通路的关系 被引量:7

Relationship between C-C chemokine receptor type 2 and P38 mitogen-activated protein kinase signaling pathway in the spinal cord of rats with bone cancer pain
原文传递
导出
摘要 目的探讨骨癌痛大鼠脊髓趋化因子受体2(CCR2)与P38丝裂原活化蛋白激酶(P38MAPK)信号通路的关系,进一步明确骨癌痛的发生机制。方法健康雌性SD大鼠共92只,其中60只利用纤毛机械刺激针方法用于行为学试验,采用随机数字表法分为以下6组(n=10);假手术组(S组)、骨癌痛组(B组)、假手术+二甲亚砜(DMSO)溶剂组(SD组)、骨癌痛+DMSO组(BD组)、假手术+RS102895 CCR2抑制剂组(SR组)、骨癌痛+RS102895 CCR2抑制剂组(BR组)。另外32只SD大鼠采用随机数字表法分为以下8组(n=4);假手术组(S组)、骨癌痛5d组(B5组)、骨癌痛9d组(B9组)、骨癌痛14d组(B14组)、骨癌痛+DMSO溶剂组(BD组)、骨癌痛+RS102895 CCR2抑制剂后0.5h组(BR0.5h组)、骨癌痛+RS102895 CCR2抑制剂后4h组(BR4h组)、骨癌痛+RS102895 CCR2抑制剂后12h组(BR12h组),通过蛋白质印迹法(Western Blot)检测大鼠脊髓P38蛋白、磷酸化的P38(p-P38)和CCR2的表达水平。结果S组造模后5、7、9、14、21d的机械缩足反应阈值分别为(30.9±1.5)、(31.9±1.2)、(32.0±1.1)、(31.6±1.5)、(32.2±1.4)g,B组分别为(26.4±0.7)、(24.4±0.8)、(21.4±0.8)、(13.5±0.4)、(9.9±0.2)g,与S组比较,B组造模后5、7、9、14、21d时机械痛阈值降低,差异均有统计学意义(t=-13.177、-16.660、-23.778、-35.574、-48.401,均P〈0.01)。造模后第9天,SD组、BD组、SR组和BR组给药后4h机械缩足反应阈值分别为(32.4±1.7)、(19.4±1.1)、(32.1±1.3)、(26.3±1.0)g,差异有统计学意义(F=224.681,P〈0.01);与SD组比较,BD组机械痛阈值降低;与BD组比较,BR组机械痛阈值升高。S组、B5组、B9组、B14组大鼠脊髓P—P38表达水平分别为(0.08±0,03)、(0.20±0,05)、(0.40±0.17)、(0.65±0.14),CCR2表达水平分别为(0.08±0.04)、(0.18±0.05)、(0.30±0,09)、(0.58±0.07),差异均有统计学意义(F=19.123、40.746,均P〈0.01);与S组比较,B9组大鼠脊髓p-P38和CCR2表达上调。造模后第9天,BD组、BR0.5h组、BR4h组和BRl2h组大鼠脊髓p-P38表达水平分别为(0.57±0.06)、(0.17±0.11)、(0.03±0.01)、(0.25±0.11),差异有统计学意义(F=29.582,P〈0.01);与BD组比较,BR0.5h组、BR4h组、BR12h组大鼠脊髓p-P38表达明显下调。结论脊髓CCR2可能通过激活P38MAPK信号通路参与了大鼠骨癌痛痛觉过敏的发生。 Objective To investigate the relationship between C-C chemokine receptor type 2 (CCR2) and P38 mitogen-activated protein kinase (P38MAPK) signaling pathway in the spinal cord of rats and further clarify the mechanism of bone cancer pain (BCP). Methods A total of 92 healthy female SD rats, of which 60 were subjected to behavioral tests using a ciliary mechanical stimulation needle. SD rats were randomly divided into six groups:sham operation group (group S), bone cancer pain group (group B ), sham operation + DMSO solvent group (group SD ), bone cancer pain + DMSO solvent group (group BD) , sham operation + RS102895 CCR2 inhibitor group ( group SR) , bone cancer pain + RS102895 CCR2 inhibitor group (group BR), and Van Frey was used in the behavioral test. Another 32 SD rats were randomly divided into the following 8 groups ( n = 4) : sham operation group ( group S), bone cancer pain 5 d group ( group B5 ), bone cancer pain 9 d group ( group B9 ), bone cancer pain 14 d group ( group B14 ), bone cancer pain + DMSO solvent group ( group BD ) , bone cancer pain + RS102895 CCR2 inhibitor 0. 5 h group (group BR0. 5 h), bone cancer pain + RS102895 CCR2 inhibitor 4 h group (group BR4 h), bone cancer pain + RS102895 CCR2 inhibitor 12 h group (group BR12 h). Western blot was used to detect the expression of P38, p-P38 and CCR2 in spinal cord of rats. Results At day 5,7,9, 14,21 post-injection,mechanical withdrawal thresholds of group S were(30. 9 ± 1.5), (31.9± 1.2), (32. 0 ± 1.1 ), (31.6 ± 1.5), (32. 2 ± 1.4)g respectively, the mechanical withdrawal thresholds of group B were( 26.4 ±0. 7 ), ( 24.4±0. 8 ), ( 21.4 ± 0. 8 ), ( 13. 5 ±0. 4 ), ( 9. 9 ± 0. 2 ) g respectively, the mechanical withdrawal thresholds in group B decreased obviously versus group S, and the differences were statistically significant (t = - 13. 177, - 16. 660, - 23. 778, - 35. 574, - 48.401, all P 〈 0. 01 ). At day 9 post-injection, the mechanical withdrawal thresholds in SD, BD, SR and BR groups were ( 32. 4 ± 1.7 ), ( 19.4 ± 1. 1 ), ( 32. 1 ± 1.3 ), ( 26. 3±1. 0) g respectively, the difference was statistically significant ( F = 224. 681, P 〈 0.01 ) , and the mechanical withdrawal thresholds in group BD decreased obviously versus group SD, while the mechanical withdrawal thresholds in group BR increased obviously versus group BD. The expression levels of p-P38 in spinal cord of group S, group B5, group B9 and group B14 were(0. 08 ±0. 03), (0. 20 v0. 05), ( 0. 40 ± 0. 17 ), (0. 65 ± 0. 14 ) respectively, the expression levels of CCR2 were ( 0. 08± 0.04 ), ( 0. 18 ±0. 05 ), (0. 30 ± 0. 09 ), ( 0. 58 ± 0. 07 ) respectively, the difference was statistically significant ( F = 19. 123, 40. 746,all P 〈0. 01 ),and the expression of p-P38 and CCR2 in group B9 were showed a significant upregulation versus group S. The expression levels of p-P38 in spinal cord of group BD, group BRO. 5 h, group BR4 h and group BR12 h were (0.57 ±0.06), (0.17 ± 0.11), (0.03 ± 0.01), (0.25 ± 0.11) respectively, and the difference was statistically significant ( F = 29. 582, P 〈 0.01 ). The expression of p-P38 in group BR0. 5 h, BR4 h, BR12 h showed a significant down-regnlation versus group BD. Conclusion CCR2 in the spinal cord may be involved in the development of bone cancer pain by activating P38MAPK signaling pathway in rats.
出处 《中华医学杂志》 CAS CSCD 北大核心 2018年第4期289-293,共5页 National Medical Journal of China
基金 国家自然科学基金(81341035,81471136) 浙江省自然科学基金(LY16H090016,LY17H090019) 浙江省医药卫生省部培育计划(2015PYA010) 浙江省卫生高层次创新人才培养项目(2012-RC-22) 浙北麻醉学区域专病中心项目 浙江省中西医结合疼痛医学重点学科建设项目(2012-XKA31) 嘉兴市科技计划项目(2017AY33008)
关键词 受体 趋化因子 P38丝裂原活化蛋白激酶 疼痛 Receptors, chemokine P38 mitogen-activated protein kinases Pain
  • 相关文献

参考文献2

二级参考文献21

  • 1Rubens RD. Bone metastases-the clinical problem. Eur J Cancer, 1998, 34: 211-213.
  • 2Medhursta SJ, Walker K, Bowes M, et al. A rat model of bone cancer pain, Pain, 2002, 96:129-140.
  • 3Zhang RX, Liu B, Wang L, et al. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain, 2005, 118 : 125-136.
  • 4Schwei MJ, Honore P, Rogers SD, et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci ,1999, 19: 10886-10897.
  • 5Halvorson KG, Kubota K, Sevcik MA, et al. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res, 2005, 65 : 9426-9435.
  • 6Walker K. Fox AJ, Urban LA. Animal models for pain research. Mol Med Today, 1999, 5: 319-321.
  • 7Corbello Pereira SR, Darronqui E, Constantin J, et al. The urea cycle and related pathways in the liver of Walker-256 tumorbearing rats. Biochim Biophys Acta, 2004, 1688: 187-196.
  • 8Yao YM, Liu QG, Yang W, et al. Effect of spleen on immune function of rats with liver cancer complicated by liver cirrhosis. Hepatobiliary Pancreat Dis Int, 2003, 2: 242-246.
  • 9Chew EC, Wallace AC. Demonstration of fibrin in early stages of experimental metastases. Cancer Res, 1976, 36:1904-1909.
  • 10Menendez L, Lastra A, Fresno MF et al. Initial thermal heat hypoalgesia and delayed hyperalgesia in a routine model of bone cancer pain. Brain Res, 2003, 969: 102-109.

共引文献62

同被引文献49

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部